Preview Mode Links will not work in preview mode

This Week in Cardiology

Apr 22, 2022

Critiques of last week’s comments on VT ablation and a review of EHRA presentations, including new ways to ablate atrial myocardium and pace the ventricle, are discussed by John Mandrola, MD, in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

I – VT ablation

- VT Ablation After First ICD Shock Boosts Survival: PARTITA

- Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial

- Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

- Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

II – Pulsed-Field Ablation

- Pulsed Field Ablation Treats AF With Few Complications

- Pulsed Field Ablation for Persistent Atrial Fibrillation (PersAFOne): Hope or Hype?

III – High-Power Short Duration Ablation

- Short, High-Power Ablation on Par With Standard AF Ablation

IV – LBB-Area Pacing

- MELOS: LBB Area Pacing Promising for Bradyarrhythmias, HF

Also of interest...

- Conduction System Pacing Noninferior to Biventricular Pacing for HF With Wide QRS

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD

Questions or feedback, please contact